This post-COVID-19 inflammatory syndrome was originally diagnosed as Kawasaki disease; however, patients with MIS-C display more pronounced lymphopenia, thrombocytopenia, anemia, and elevated serum IFN-γ, IL-1β, IL-6, IL-10, and IL-17 levels (377, 378). Here, IL17A is linked to COVID-19.